NEW YORK (GenomeWeb News) – Qiagen disclosed in its 2013 annual report filed with the US Securities and Exchange Commission that it acquired CLC Bio for $68.2 million, net of cash acquired. It added in the document that the deal was "not significant" to its overall consolidated financial statements. Qiagen announced the acquisition in October but had not disclosed the financial terms at that time.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Though many details have yet to be worked out, the draft deal for the UK's withdrawal from the EU is giving researchers some hints for what they can expect, Nature News says.

DNA testing has solved a 100-year-old mystery contained in the skull and teeth samples of a now-extinct monkey that once inhabited Jamaica, Gizmodo reports.

As the UN ponders a ban on gene drives, one malaria researcher says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.

In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.